Pharmafile Logo
Pharmafocus logo
Advanced Search
Orencia image

BMS backs rheumatoid arthritis prevention trial

March 27, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, Orencia, RA, abatacept, rheumatoid arthritis

Bristol-Myers Squibb is funding a £3 million trial of Orencia as a preventative treatment for rheumatoid arthritis. The study will …

News
Novo image

Novo resubmits FDA application for two diabetes drugs

March 27, 2015
Sales and Marketing Danish, FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes

Novo Nordisk will re-submit an FDA application for its diabetes drugs Tresiba and Ryzodeg two years after their initial rejection …

News
Daiichi image

Daiichi Sankyo cuts 16% of US staff

March 27, 2015
Sales and Marketing Benicar, Daiichi Sankyo, FDA, Ranbaxy, Welchol, ambit, colesevelam, cuts, olmesartan

Daiichi Sankyo is laying off 16% of its staff at its US commercial headquarters as the company braces itself for …

News
Genome image

Big pharma teams with government on genomic research

March 27, 2015
Research and Development, Sales and Marketing AbbVie, Alexion Pharmaceuticals, AstraZeneca, Biogen, Cameron, Dimension Therapeutics, GSK, Genomic, Genomics england, Helomics, Roche, Takeda, UCB, UK, genomes

Ten firms will partner up with Genomics England to develop new diagnostics and treatments for people with rare diseases and …

News
terry_salyer

BioNano Genomics appoints chief commercial officer

March 27, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioNano Genomics, Terry Salyer

Genome mapping San Diego firm BioNano Genomics has appointed Terry Salyer as its chief commercial officer. Salyer has more than …

Appointment

Pharma contributes £32 billion to UK economy

March 26, 2015
Sales and Marketing Asia, IFPMA, Oceania, UK, economy, freeman, pharma

Pharma generated over half of the UK life sciences industry’s turnover in 2014 according to a report from the Department …

News

Pharma’s global economic footprint is huge – and growing

March 26, 2015
Research and Development, Sales and Marketing Argentina, Asia, IFPMA, Oceania, global, gva, pharma

The pharma industry contributes more than $400 billion to the global economy, according to new research that examines the worldwide …

News
Sun Pharmaceutical Industries, India

Sun Pharma completes Ranbaxy acquisition

March 26, 2015
Manufacturing and Production, Sales and Marketing Daiichi Sankyo, India, Ranbaxy, Sun Pharma, cci

Sun Pharma has closed its mega merger deal with Ranbaxy and begun the integration of the two businesses. The combined …

News

£3 million government boost for stem cells

March 26, 2015
Research and Development, Sales and Marketing NHS Blood and Transplant, Stem cells, UK, george freeman, government

The UK government will invest £3 million to further improve the provision of stem cells in the UK which will …

News
Bayer image

Bayer and Regeneron eye drug gains another indication

March 26, 2015
Sales and Marketing Bayer, Eylea, FDA, Japan, Lucentis, MRI, Regeneron, aflibercept

Bayer and Regeneron’s Eylea has added to a growing list of indications with its new approval to treat a type …

News

WHO: New measures needed to reduce high drug costs

March 26, 2015
Research and Development, Sales and Marketing Europe, WHO, pricing, transparency, world health organization

New approaches to drug pricing and reimbursement are needed to make sure pharma provides access to new medicines, according to …

News

NHS in England is ‘deteriorating’

March 26, 2015
Sales and Marketing Conservatives, England, Labour, NHS, coalition, election, government, liberal

Leading UK healthcare think tank The King’s Fund has published its second report on the NHS under the present government …

News
NICE image

NICE decisions made on Bayer, Celgene and Boehringer drugs

March 26, 2015
Sales and Marketing Bayer, Boehringer, Celgene, NHS, Xarelto, imnovid, jardiance

In final guidance NICE has recommended Bayer’s Xarelto and Boehringer’s Jardiance for NHS funding, but not Celgene’s Imnovid. Bayer’s Xarelto …

News
andrew_jenkins

Two new directors for The Purple Agency

March 26, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Jenkins, Terri Martin, purple agency

UK communications firm The Purple Agency has appointed two new directors to its healthcare team. Andrew Jenkins (pictured) who was …

Appointment
GSK image

GSK seeks development proposals from academics

March 25, 2015
Research and Development, Sales and Marketing GSK, academics, fast track challenge, proposals

Registration has opened for GlaxoSmithKline’s third annual Discovery Fast Track challenge, which sees the company searching for new drug discovery …

News
Homeopathy image

FDA to review homeopathy rules

March 25, 2015
Research and Development, Sales and Marketing Australian Government’s National Health and Medical Research Council, FDA, homeopathy

The FDA is to hold a public meeting to “obtain information and comments from stakeholders” on the use of homeopathic …

News
Apps image

NHS launches mental health apps library

March 25, 2015
Medical Communications, Sales and Marketing England, NHS, apps, choices, digital, kitemark, online

NHS England has launched a directory of digital services it endorses for the treatment of mental health, in the first …

News
capture

NICE names new non-executive director

March 25, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, tim irish

The Department of Health has appointed Tim Irish as a non-executive director of the National Institute for Health and Care …

Appointment
Keytruda image

Merck’s Keytruda trial stopped early after beating BMS’ Yervoy on survival

March 25, 2015
Research and Development, Sales and Marketing BMS, Merck, Yervoy, ipilimumab, keytruda, pembrolizumab

A trial comparing two potential blockbuster cancer treatments has been stopped early, after Merck’s Keytruda beat BMS’ Yervoy in a …

News
Astrazeneca image

AstraZeneca and Harvard team up for diabetes research

March 25, 2015
Research and Development, Sales and Marketing AZ, AstraZeneca, Havard, cardiovascular, diabetes, metabolic

AstraZeneca is to work with Harvard University’s department of stem cell and regenerative biology to develop new treatments in diabetes. …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026